University Hospital Expands Stroke Treatment Window

Got story updates? Submit your updates here. ›

University Hospital in San Antonio is at the forefront of advancing stroke care, with clinical trials that are dramatically expanding the treatment window for both intravenous clot-busting medication and thrombectomy procedures. These breakthroughs are offering hope to more stroke patients than ever before by extending the timeframe for critical interventions.

Why it matters

Stroke is a leading cause of death and disability, and rapid treatment is essential to minimize brain damage. University Hospital's research is redefining the treatment paradigm, which could save countless lives and improve outcomes for stroke patients across San Antonio and beyond.

The details

Recent trials at University Hospital have shown the benefits of extending the time window for IV clot-busting medication to up to 24 hours, a significant leap from the previous 4.5-hour limit. The hospital is also participating in the SELECT LATE trial, investigating the potential to perform thrombectomies - the physical removal of blood clots - up to 72 hours after symptom onset, well beyond the previous 24-hour timeframe.

• The traditional time window for effective stroke treatments was 4.5 hours.
• Recent University Hospital trials have extended the IV medication window to up to 24 hours.
• The SELECT LATE trial is exploring thrombectomy procedures up to 72 hours after symptom onset.

What’s next

The ongoing research and trials in San Antonio suggest a future where stroke treatment is even more personalized and effective, with continued refinement of protocols, wider adoption of advanced imaging techniques, and a greater emphasis on rehabilitation and long-term recovery.